Overview
Midori Hoshi-Nakamura practices practicing medicine in Tokyo, Japan.
Her clinical expertise encompasses Adult T-Cell Leukemia and Severe Acute Respiratory Syndrome (SARS).
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Midori Hoshi-Nakamura
Is Midori Hoshi-Nakamura a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Midori Hoshi-Nakamura is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Midori Hoshi-Nakamura participate in research or clinical trials?
Yes. Midori Hoshi-Nakamura has published 11 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Midori Hoshi-Nakamura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult T-Cell LeukemiaMs. Hoshi-Nakamura isExperienced. Learn about Adult T-Cell Leukemia.
- Severe Acute Respiratory Syndrome (SARS)Ms. Hoshi-Nakamura isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).